Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hydrocortisone + iodoquinol is a topical combination drug used to treat various **inflammatory and infectious skin conditions**, such as eczema, dermatitis, and superficial bacterial or fungal infections[1][2][3][5][6][7][8][9]. Hydrocortisone is a corticosteroid that reduces inflammation, itching, and redness primarily by suppressing leukocyte migration and reversing capillary permeability[1][2][3]. Iodoquinol functions as an antifungal and antibacterial agent, disrupting the growth and viability of susceptible microorganisms on the skin[1][2][3]. This combination is commonly supplied as a cream or gel for external application to the affected skin[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hydrocortisone + iodoquinol.